• CHEMBL2431768 CHEMBL2431768 Antineoplastic

    Alternate Names:

    (2S)-N-[(1S)-1-CYCLOHEXYL-2-[(2S)-2-[4-(4-FLUOROBENZOYL)-1,3-THIAZOL-2-YL]PYRROLIDIN-1-YL]-2-OXOETHYL]-2-METHYLAMINOPROPANAMIDE
    (S)-N-((S)-1-CYCLOHEXYL-2-((S)-2-(4-(4-FLUOROBENZOYL)THIAZOL-2-YL)PYRROLIDIN-1
    S7009,1005342-46-0
    Z-3226
    KB-193680
    KB-135628
    HY-15518
    BC600325
    CS-1630
    ZINC95929260
    BDBM50441356
    2508AH
    MOLPORT-035-789-707
    AOB4073
    SCHEMBL1275369
    GTPL7912
    C26H33FN4O3S
    (S)-N-((S)-1-CYCLOHEXYL-2-((S)-2-(4-(4-FLUOROBENZOYL)THIAZOL-2-YL)PYRROLIDIN-1-YL)-2-OXOETHYL)-2-(METHYLAMINO)PROPANAMIDE
    (2S)-N-[(1S)-1-CYCLOHEXYL-2-[(2S)-2-[4-(4-FLUOROBENZOYL)-1,3-THIAZOL-2-YL]PYRROLIDIN-1-YL]-2-OXOETHYL]-2-(METHYLAMINO)PROPANAMIDE
    LCL 161
    6TNS415Y3P
    UNII-6TNS415Y3P
    LCL-161
    1005342-46-0
    24737642
    LCL161
    249565595
    7912

    Drug Info:

    (0 More Sources)

    Publications:

  • Interaction Types:
    antagonist
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assay uses recombinantly expressed BIR3 domain of cIAP1
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    antagonist
    inhibitor

    Interaction Info:
    Details of the Assay for Interaction Assay uses recombinantly expressed BIR3 domain of XIAP
    Specific Action of the Ligand Inhibition
    Endogenous Drug? False

    Publications:

  • Interaction Types:
    antagonist

    Interaction Info:
    Notes

    Publications:

    • Version: 27-September-2017

    Alternate Names:
    LCL161 GuideToPharmacology Ligand Name
    249565595 PubChem Drug SID

    Drug Info:

    Publications:

    • Version: 09-Feb-2016

    Alternate Names:
    LCL161 pubchem_primary_name
    24737642 PubChem CID
    1005342-46-0 Drug Synonym

    Drug Info:

    Publications:

    • Version: 12-May-2016

    Alternate Names:
    LCL161 Primary Drug Name
    LCL161 Drug Synonym

    Drug Info:

    Publications: